Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor

Cancer Communications(2020)10.1002/cac2.12040Source: DataRank Database

Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor is a research paper published in Cancer Communications (2020). On theSindex it has a DataRank of 0. It has been cited 40 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access40 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.98)OA: goldTopics (60)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Ning Ji ORCID,Chao‐Yun Cai,Jing‐Quan Wang ORCID,Zi‐Ning Lei ORCID,Qiu‐Xu Teng

Live enrichment

PubMed:32525624 OpenAlex:https://openalex.org/W3032966509

National Natural Science Foundation of China

Grant: 81872901

National Institutes of Health

Grant: 1R15GM116043‐01

National Institutes of Health

Grant: 1R15GM116043-01

Nanowaveguide Illuminated Fluorescence Spectroscopy for Studying Membrane Protein Dynamics

NIGMS NIH HHS

Grant: R15 GM116043

FWCI

1.98

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: CC BY NC ND

journalhttps://doi.org/10.1002/cac2.12040

publisherhttps://doi.org/10.1002/cac2.12040

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcac2.12040

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12040

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cac2.12040

Fields of Study

Drug Transport and Resistance MechanismsMetal complexes synthesis and propertiesLiver physiology and pathology0301 basic medicine03 medical and health sciencesATP Binding Cassette Transporter, Subfamily BAnilidesAnimalsAntineoplastic AgentsCell Line, TumorDrug Resistance, NeoplasmHumansATP-Binding Cassette, Sub-Family C ProteinsProtein Kinase InhibitorsPyridinesXenograft Model Antitumor Assays

MeSH Terms

AnilidesAnimalsAntineoplastic AgentsHumansPyridinesATP Binding Cassette Transporter, Subfamily BDrug Resistance, NeoplasmXenograft Model Antitumor AssaysMultidrug Resistance-Associated ProteinsATP-Binding Cassette, Sub-Family C ProteinsCell Line, TumorProtein Kinase Inhibitors

Keywords

PharmacologyATP-binding cassette transporterMultiple drug resistanceMTT assayTyrosine-kinase inhibitorChemistryIn vivoIn vitroEffluxTyrosine kinaseCytotoxicityBiologyBiochemistryTransporterSignal transductionCancerGeneATP-Binding Cassette, Sub-Family C ProteinsATP Binding Cassette Transporter, Subfamily BPyridinesSitravatinibNeoplasms. Tumors. Oncology. Including cancer and carcinogensAntineoplastic AgentsOriginal ArticlesXenograft Model Antitumor AssaysDrug Resistance, NeoplasmCell Line, TumorAnimalsHumansAnilidesProtein Kinase InhibitorsRC254-282

Sustainable Development Goals

SDG 0: Good health and well-being